Scalp block versus general anesthesia for burr‑hole evacuation of subdural hematoma
Scalp Block Versus General Anesthesia in Patients Undergoing Evacuation of Subdural Hematoma Via Burr Hole
This trial tests whether using a scalp block instead of general anesthesia helps adults (18–75) having burr‑hole evacuation of a subdural hematoma.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 80 (estimated) |
| Ages | 18 Years to 75 Years |
| Sex | All |
| Sponsor | Sohag University Academic / other |
| Locations | 1 site (Sohag) |
| Trial ID | NCT07143799 on ClinicalTrials.gov |
What this trial studies
Adults with subdural hematoma who meet eligibility criteria will be assigned to receive either a scalp block (local anesthetic) or standard general anesthesia (including cisatracurium for muscle relaxation) for burr‑hole evacuation. The study will compare intraoperative stability, postoperative pain control, immediate complications, and early recovery measures between the two approaches. Key inclusion criteria include age 18–75, ASA II–III, and GCS ≥8, while patients with coagulopathy, local infection, significant heart block, or known drug sensitivity are excluded. The procedure and assessments are conducted at a single center (Sohag University Hospital).
Who should consider this trial
Good fit: Adults 18–75 with subdural hematoma scheduled for burr‑hole evacuation who are ASA II–III, have GCS ≥8, and do not have coagulopathy, infection at the injection site, heart block, or known sensitivity to study drugs are ideal candidates.
Not a fit: Patients with GCS <8, impaired coagulation, active infection at the injection site, significant heart block, or allergy to the study drugs are unlikely to benefit or be eligible.
Why it matters
Potential benefit: If successful, this approach could reduce anesthesia‑related risks and improve pain control and early recovery after burr‑hole evacuation.
How similar studies have performed: Scalp block has been used in cranial surgery to reduce pain and blunt hemodynamic responses, but evidence specifically for burr‑hole evacuation is limited.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria * Age from 18 to 75 years old. * Both sexes. * American Society of Anesthesiologists (ASA) physical status II-III. * Patients with subdural hematoma undergoing burr-hole evacuation Exclusion Criteria: * Patients with a history of known sensitivity to study drugs. * Glasgow Coma Scale (GCS) \<8 * Impaired coagulation profile. * Any degree of heart block. * Infection at site of injection
Where this trial is running
Sohag
- Sohag university hospital — Sohag, Egypt (Recruiting)
Study contacts
- Study coordinator: Mohamed H elsayed, Resident
- Email: sakr422022@gmail.com
- Phone: 01050053614
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.